Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Auxilium Pharmaceuticals,
Develops and markets pharmaceutical products

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.

It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons.

The company currently markets two products in the United States: Testim testosterone gel and XIAFLEX.

The Testim testosterone gel is a proprietary, topical testosterone once-a-day gel indicated for the treatment of hypogonadism.

The XIAFLEX is a proprietary, injectable collagenase enzyme approved by the United States Food and Drug Administration for the treatment of Dupuytren's contracture in adult patients with a palpable cord.

Auxilium Pharmaceuticals was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA.

Number of employees : 639 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products395.28100%400.72100% +1.36%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States288.6273%378.1894.4% +23.68%
International106.6727%22.545.6% -373.27%
Managers
NameAgeSinceTitle
Adrian Adams632011President, Chief Executive Officer & Director
Rolf A. Classon692004Non-Executive Chairman
Andrew Saik, MBA-2014Chief Financial Officer
James Patrick Tursi, MD492009Chief Medical Officer
William T. McKee522009Independent Director
Paul A. Friedman, MD712010Independent Director
Peter C. Brandt, MBA572010Independent Director
Nancy Sue Lurker, MBA562011Independent Director
Oliver Steffen Fetzer PhD, MBA502005Independent Director
Keri P. Mattox--SVP-Investor Relations & Corporate Communications
Shareholders
NameShares%
Deerfield Management Co. LP 6,267,38212.4%
Fidelity Management & Research Co. 5,987,69511.9%
Palo Alto Investors LLC 4,854,6319.64%
Paulson & Co., Inc. 4,000,0007.94%
BlackRock Fund Advisors 3,427,7196.81%
The Vanguard Group, Inc. 3,022,3016.00%
SSgA Funds Management, Inc. 2,284,2424.54%
Wellington Management Co. LLP 2,190,0234.35%
Invus Public Equities Advisors LLC 2,015,0004.00%
ClearBridge Investments LLC 1,571,8743.12%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating
Growth (Revenue)
Valuation -
Finances
Profitability
Earnings quality
Business Predictability
PER -
Potential
Yield -
Consensus
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
ASTRAZENECA PLC
CELGENE CORPORATI..
BIOGEN IDEC INC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
CUBIST PHARMACEUT..
CHONGQING ZHIFEI ..
-
BEIJING TIANTAN B..
-
CELLDEX THERAPEUT..
THERAVANCE INC
AUXILIUM PHARMACE..
WALVAX BIOTECHNOL..
-
GREEN CROSS CORP
ARIAD PHARMACEUTI..
Sector Pharmaceuticals
Company contact information
Auxilium Pharmaceuticals, Inc.
640 Lee Road
Chesterbrook, PA 19087

Phone : +1.484.321.5900
Fax : +1.484.321.5999
Web : www.auxilium.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF